REVB Revelation Biosciences reports vastly wider Q4 2025 loss than estimates shares end flat for the trading day MillerKnoll MLKN Stock Is It Losing Strength MillerKnoll posts 63 EPS miss vs analyst targets Illumina ILMN Management Strategy Q4 2025 Better Than Expected